Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis
Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology. Findings were published in Physiological Genomics.
“Our findings pave the way to precision medicine for cystic fibrosis patients, eventually helping us match treatment to each patient’s unique genomic pattern of disease,” says lead author Hara Levy, MD, MMSc, from Manne Research Institute at Lurie Children’s, who is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “Our study was the first to identify molecular signatures of cystic fibrosis from a blood test taken during a routine clinic visit, giving us a baseline. Greater understanding of these molecular signatures may lead to unique molecular markers that could help us intervene earlier to changes in a patient’s inflammatory response to airway infection or pancreatic function, allowing us to provide more focused treatment. It would be a huge improvement over the one-size-fits-all treatment approach we currently have for patients with cystic fibrosis.”
To identify baseline molecular signatures in cystic fibrosis, Dr. Levy’s lab obtained genomic information from patients’ blood samples using cutting-edge technologies such as Affymetric array and Illumina MiSeq. The team then merged this genomic information with each individual’s clinical history gathered from electronic medical records. They compared this snapshot of patient-specific data with healthy controls. Their study provides strong evidence for distinct molecular signatures in cystic fibrosis patients that correlate with clinical outcomes.
Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. Currently, the average predicted survival is 47 years. Although cystic fibrosis is caused by dysfunction of a single gene (CFTR) and treatment that targets CFTR mutations is available, the relationships between the abnormal gene product, development of inflammation and disease progression are not fully understood. This limits the ability to predict a patient’s clinical course, provide individualized treatment and rapidly monitor treatment response.
For example, it is not clear why patients with cystic fibrosis are susceptible to chronic lung infections, since they are considered to have a functional immune system.
“We are now trying to discover why patients with cystic fibrosis become infected so easily,” says Dr. Levy. “We are taking a closer look at the immune cells that make up many of the molecular signatures we found in cystic fibrosis.”
More study is needed before precision medicine for cystic fibrosis reaches the clinic.
“With more research, a blood test to gather genomic specifics of each patient’s disease might be available in the clinic within the next five years,” says Dr. Levy. “Precision medicine will revolutionize care for cystic fibrosis patients.”
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- Kansas girl dies after 18 years of fighting Cystic Fibrosis on December 16, 2018 at 3:00 pm
TOPEKA, Kan. (WIBW) The family of Madison Taliaferro says the 18-year-old Holton girl died Saturday evening. She had been waiting for a new lung transplant after lung function fell from 48 percent to ... […]
- Jacksonville teen dies after battle with cystic fibrosis on December 15, 2018 at 5:04 pm
JACKSONVILLE, Fla. — A Jacksonville teen died Saturday afternoon after a long battle with cystic fibrosis, her parents said. Chrissy Van Der Velden, 17, died at 4:45 p.m., according to her father, Wil... […]
- Hypertonic Saline Inhalation Safety Tested in Infants With Cystic Fibrosis on December 14, 2018 at 6:23 am
HealthDay News — In infants with cystic fibrosis (CF), preventive inhalation with hypertonic saline (HS) during the first months of life is safe and well tolerated and results in clinical improvements ... […]
- Parents of teen with cystic fibrosis prepare to say goodbye as health takes a turn for the worse on December 13, 2018 at 9:27 pm
On Friday, First Coast News told viewers about one family’s Christmas miracle. The parents of Chrissy Van Der Velden, 17, were overjoyed when she came out of a coma after battling cystic fibrosis. Sad... […]
- Man with cystic fibrosis is ecstatic to learn he's getting a new set of lungs on December 13, 2018 at 3:29 pm
This is the thrilling moment a cystic fibrosis patient learns he’s approved for a lung transplant operation. Kevin D’Agostino was born with the disease that causes severe lung infections due to a buil... […]
- Blood Test Could Lead to Cystic Fibrosis Treatment Tailored to Each Patient on December 13, 2018 at 1:57 am
Newswise — Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify d... […]
- Blood test helps identify distinct molecular signatures in children with cystic fibrosis on December 12, 2018 at 8:53 pm
Researchers at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct mol... […]
- AR-501 (Cystic Fibrosis) Enrolls First Subject in Phase 1/2a Clinical Trial for Treatment of Chronic Lung Infections in Cystic Fibrosis Patients on December 12, 2018 at 4:46 am
- Two-Part Randomized, Double-Blinded Placebo Controlled Clinical Study in Healthy Subjects Followed by Cystic Fibrosis Patients Enrolls First Adult Human Volunteer - Study Being Performed in ... […]
- Saskatchewan family fights cystic fibrosis with thousands of butter tarts on December 11, 2018 at 3:20 pm
One Saskatchewan family is undertaking a big task this holiday season, baking thousands of butter tarts to raise money for cystic fibrosis. The Big Butter Tart Bake for Cystic Fibrosis is now in its f... […]
- Millcreek man battles cystic fibrosis with new lungs on December 4, 2018 at 11:10 pm
Nicholas Katsadas finally had a chance to hear his new lungs. His mother, Deanna, handed him a stethoscope Nov. 28, a month after the 21-year-old Millcreek Township man underwent a double-lung transpl... […]
via Bing News